Treatment goals for psoriasis: Should PASI 90 become the standard of care?
Actas Dermosifiliogr. 2015 Apr;106(3):155-7.
doi: 10.1016/j.ad.2014.10.001.
Epub 2014 Nov 11.
[Article in
English,
Spanish]
Affiliations
- 1 Department of Dermatology, Centro Hospitalar do Porto, Portugal; Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Portugal. Electronic address: [email protected].
- 2 Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain.
No abstract available
MeSH terms
-
Anti-Inflammatory Agents / therapeutic use
-
Antirheumatic Agents / therapeutic use
-
Clinical Trials as Topic
-
Goals
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Psoriasis / drug therapy*
-
Psoriasis / pathology
-
Severity of Illness Index*
-
Treatment Outcome
Substances
-
Anti-Inflammatory Agents
-
Antirheumatic Agents
-
Immunosuppressive Agents